BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8141809)

  • 21. Mutagenicity studies with N-acetyl-L-aspartic acid.
    Karaman S; Myhre A; Donner EM; Munley SM; Delaney B
    Food Chem Toxicol; 2009 Aug; 47(8):1936-40. PubMed ID: 19445994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic toxicology assessment of HI-6 dichloride.
    Putman D; San RH; Bigger CA; Levine BS; Jacobson-Kram D
    Environ Mol Mutagen; 1996; 27(2):152-61. PubMed ID: 8603667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotoxicity assessment of S-equol in bacterial mutation, chromosomal aberration, and rodent bone marrow micronucleus tests.
    Schwen R; Jackson R; Proudlock R
    Food Chem Toxicol; 2010 Dec; 48(12):3481-5. PubMed ID: 20875837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential carcinogenicity assessment of alpha-aescin and phenbendasol.
    Przybojewska B; Barański B; Spiechowicz E; Dziubałtowska E; Szymczak W
    Acta Pol Pharm; 1994; 51(1):89-93. PubMed ID: 7976438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenicity of industrial compounds. VII. Styrene and styrene oxide: II. Point mutations, chromosome aberrations and DNA repair induction analyses.
    Loprieno N; Presciuttini S; Sbrana I; Stretti G; Zaccaro L; Abbondandolo A; Bonatti S; Fiorio R; Mazzaccaro A
    Scand J Work Environ Health; 1978; 4 Suppl 2():169-78. PubMed ID: 366743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagenicity of the new quinolone antibacterial agent levofloxacin.
    Shimada H; Itoh S; Hattori C; Tada S; Matsuura Y
    Arzneimittelforschung; 1992 Mar; 43(3A):378-85. PubMed ID: 1622436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutagenicity study of the new cephalosporin antibiotic cefditoren pivoxil.
    Shindo Y; Hayashi H; Ando M; Tatebayashi T
    Arzneimittelforschung; 1996 Aug; 46(8):815-21. PubMed ID: 9125285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the mutagenic potential of ubidecarenone using three short-term assays.
    Kitano M; Hosoe K; Fukutomi N; Hidaka T; Ohta R; Yamakage K; Hara T
    Food Chem Toxicol; 2006 Mar; 44(3):364-70. PubMed ID: 16198039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotoxicity of aloeemodin in vitro and in vivo.
    Heidemann A; Völkner W; Mengs U
    Mutat Res; 1996 Mar; 367(3):123-33. PubMed ID: 8600368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of DNA damage induction by okadaic acid, a marine toxin, in the CHO-Hprt and the in vitro UDS assays.
    Le Hégarat L; Nesslany F; Mourot A; Marzin D; Fessard V
    Mutat Res; 2004 Dec; 564(2):139-47. PubMed ID: 15507378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity of Echinacea purpurea. Acute, subacute and genotoxicity studies.
    Mengs U; Clare CB; Poiley JA
    Arzneimittelforschung; 1991 Oct; 41(10):1076-81. PubMed ID: 1799389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the mutagenic and genotoxic potential of ubiquinol.
    Kitano M; Mizuhashi F; Kubo H; Kishida H; Fujii K; Kitahara M; Hosoe K
    Int J Toxicol; 2007; 26(6):533-44. PubMed ID: 18066969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of mutagenic, genotoxic and transforming properties of Ukrain.
    Chłopkiewicz B; Marczewska J; Ejchart A; Anuszewska E; Koziorowska J
    Drugs Exp Clin Res; 1992; 18 Suppl():31-4. PubMed ID: 1305040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the genotoxic potential of the natural neurotoxin Tetrodotoxin (TTX) in a battery of in vitro and in vivo genotoxicity assays.
    Guzmán A; Fernández de Henestrosa AR; Marín AP; Ho A; Borroto JI; Carasa I; Pritchard L
    Mutat Res; 2007 Dec; 634(1-2):14-24. PubMed ID: 17881283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenic activity of p-toluenesulfonhydrazide.
    Blakey DH; Nestmann ER; Bayley JM; Maus KL; Douglas GR
    Toxicol Ind Health; 1992; 8(6):369-76. PubMed ID: 7570619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenic and antimutagenic effects of 5-substituted 2'-deoxyuridines depending on the nature of the 5-substituent.
    Marquardt H; Westendorf J; Schaefer A; Boldt J; De Clercq E; Marquardt H
    Arzneimittelforschung; 1988 Dec; 38(12):1820-4. PubMed ID: 3072958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of chemopreventive agents for genotoxic activity.
    Doppalapudi RS; Riccio ES; Rausch LL; Shimon JA; Lee PS; Mortelmans KE; Kapetanovic IM; Crowell JA; Mirsalis JC
    Mutat Res; 2007 May; 629(2):148-60. PubMed ID: 17387038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of 5-aminoisoquinoline (5-AIQ), a novel PARP-1 inhibitor for genotoxicity potential in vitro and in vivo.
    Vinod KR; Chandra S; Sharma SK
    Toxicol Mech Methods; 2010 Feb; 20(2):90-5. PubMed ID: 20102296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.